Episodes

The Electronic Health Record (EHR) is receiving considerable attention as efforts by Providers and other sectors are underway to extend capabilities and value far beyond their original intent. In this episode we are diving into the topic of looking "Beyond the EHR" and clinical data to explore how healthcare organizations are wrapping solutions around the EHR and discussing trends that not many are thinking about. To help us dive into this topic, we’ve invited Friend of Vynamic, Shahrukh Tarapor...

The Electronic Health Record (EHR) is receiving considerable attention as efforts by Providers and other sectors are underway to extend capabilities and value far beyond their original intent. In this episode we are diving into the topic of looking "Beyond the EHR" and clinical data to explore how healthcare organizations are wrapping solutions around the EHR and discussing trends that not many are thinking about. To help us dive into this topic, we’ve invited Friend of Vynamic, Shahrukh Tarapor...

Clinical research development has long been targeted as an area of opportunity for pharmaceutical companies and investigator sites to find more efficient methods of adoption to drive success in commercializing a product. Friend of Vynamic, Amy Nordo joins us on this episode as we dive into the topic of Clinical Trials and how innovation is making its way into this critical function between a pharmaceutical company and the provider settings. Resources Mindy discussed an article published by Kais...

Clinical research development has long been targeted as an area of opportunity for pharmaceutical companies and investigator sites to find more efficient methods of adoption to drive success in commercializing a product. Friend of Vynamic, Amy Nordo joins us on this episode as we dive into the topic of Clinical Trials and how innovation is making its way into this critical function between a pharmaceutical company and the provider settings. Resources Mindy discussed an article published by Kais...

Clinical research development has long been targeted as an area of opportunity for pharmaceutical companies and investigator sites to find more efficient methods of adoption to drive success in commercializing a product. Friend of Vynamic, Amy Nordo joins us on this episode as we dive into the topic of Clinical Trials and how innovation is making its way into this critical function between a pharmaceutical company and the provider settings. Resources Mindy discussed an article published by Kais...

In 2017 the US spent an estimated 450 billion dollars on prescription drugs, about 12% of the total healthcare spending. With public and political uproar surrounding the life sciences industry pricing practices, we ask “why is drug pricing so complicated?”. In this episode, we’ll discuss drug pricing and, more specifically, explore the question of why prices are so high. The panel will discuss why drug pricing is so complicated and why proposed efforts to drive down costs may have unintended and...

Recent policy discussions have centered on the headline of Medicare for All. What does Medicare for All really mean? In short, the proposed policies mean many things to many people. In today’s episode, we are chatting about Medicare for All. Just in time for the kick off to primary season we will provide you with insight into the various proposals and the potential impacts. And stay tuned for our parting thought – its that thing that we have either read, heard or seen that we recommend to you. ...

Clinical Research is traditionally thought of as an opportunity belonging to Academic Medical Centers. In this release of our Hi 5 podcast episode you will understand what clinical research is, the benefit and the challenge, but more importantly, why both sponsored and non-sponsored research should be considered a focus for all hospitals, not just AMCs. Our guest, Shirley Trainor-Thomas, President and Principal Strategist at Phase Up Research also shares her thoughts on how hospitals can evaluat...

Effective doctor-patient communication is a central clinical function in building a therapeutic doctor-patient relationship, which is the heart, and some would say the art of medicine. The panel is joined by Vynamic colleague & guest, Deepa Mischler, to discuss the "how" around improving provider/patient interactions, and friend of Vynamic, Mike Puchtler, VP Patient Experience at Christiana Care Health System. Mike’s focus is in driving excellence in patient experience at Christiana and we can’t...

The strategic process of establishing a plan that maximizes the value of a brand has been practiced in similar fashion for, well, a long time. As the healthcare landscape changes, the question the team discussed is whether the brand planning process needs to change and what are the opportunities for improvement? We will discuss the practice that Life Science brand teams employ and generally, what is and isn’t working in the process. Resources Mindy discussed a recent article published in Fierc...

The adoption of Electronic Health Records (EHR’s or EMR’s) has been, like many healthcare solutions, a revolution, with implementations happening in an extremely rapid fashion. And there are no plans on it slowing down. We discuss whether the Electronic Health Record is structured to be the ultimate gatekeeper in the industry. And joining us is guest, Chris Notti, Chief Information Strategist for Jefferson Health System to dig into the good, bad, and potential of EHRs. Resources According to t...

Digital technologies are all around us, permeating the way we work, play, and live. The team discusses the various ways in which healthcare enterprises are adopting digital solutions and the resulting impact in the healthcare industry. Resources https://www.forbes.com/sites/bernardmarr/2018/05/21/how-much-data-do-we-create-every-day-the-mind-blowing-stats-everyone-should-read/ https://medium.com/@astorya_vc/digital-health-how-technology-could-reshape-health-insurance-9e066041826d https://www....

Blockchain is entering common discussions in the healthcare industry. This emerging technology offers tremendous hope to addressing some of the largest issues in the healthcare industry including efficiency & privacy. How soon can we expect to see this hit mainstream? The panel discusses timing and use cases for Blockchain technology across the healthcare system. Resources Mindy discussed the FDA’s interest in Artificial Intelligence and the agency’s initiation of their tech incubator for AI in...

In our fast-paced world, the healthcare industry is no different in its quest to quickly and successfully transition patients through their ‘continuum of care’. Unfortunately, many times there is a knowledge gap between patient/caretaker and their respective provider, nurse, or physician. In this episode, Vynamic tries to tackle these issues and discuss the differences between ‘lowercase a’ advocates, and “capital A” Advocacy to find some solutions to mitigate these risks. Special guest and frie...

The rise of the empowered consumer is a trend healthcare organizations are trying to better understand in the context of putting the consumer in the center of healthcare. But how real is consumerism in the industry and has it had an impact? Ryan, Mindy, Mike, and guest Kristen Sherman debate what is working and what is not when it comes to empowering individuals. And stay tuned to the episodes parting thought. Resources https://www.kff.org/health-costs/report/2017-employer-health-benefits-surve...

Mindy, Ryan, and Mike discuss the powerful trends at work globally, forcing changes in how healthcare will be conceived and delivered in the future. In an interview, Sylvia Twersky, PhD, Temple University, discusses the relevant and intriguing trends across the healthcare industry. Resources https://www.chcs.org/highlight/accountable-care-organizations-in-2016-private-and-public-sector-growth-and-dispersion/ https://www.pcpcc.org/resource/national-scorecard-and-compendium-payment-reform https...

Disruptive innovation are common terms being used to describe the state of the healthcare market. Looking beyond the hype, Vynamic discusses the management framework of Disruptive Innovation and why it is difficult to achieve in the colossal healthcare industry.

With Amazon diving head first into the healthcare market, it is no longer a question of will they but what this titanic organization will do to disrupt the healthcare industry. Mindy, Ryan and Mike debate how disruptive Amazon’s entry into the market may be and which sectors could be most impacted.

The CMS and FDA have been actively promoting proposed rule changes, rolling out new programs and adopting new technologies in an effort to advance the US healthcare system and modernize their agencies. From efforts to increase transparency, waivers to experiment, and adoption of Artificial Intelligence, these agencies are taking action. The team discusses some of these activities and what the impact could be to the healthcare industry.

The healthcare services industry is going through rapid change as a slew of giant companies propose deals that may result in new value propositions to healthcare stakeholders. The panel discusses the moves being made and whether vertical integrations will result in similar outcomes.

MACRA represents a transformative shift in the direction of physician payment, and will impact strategy across the provider community. CMS contends that parts of MACRA are working and parts need a redo. Do Mindy and Ryan agree? Is MACRA achieving its intended goals of improving quality and lowering costs? They will discuss the recently concluded “transition” year and what to expect in 2018.

Mindy and Ryan are joined by friends and colleagues, Karen Baldry & Chris Savage to debate why new medicines matter. With novel therapies addressing complex disease states that come with significant price points, the panel discusses why the launch of a new product is critical for life science organizations. The panel discusses what it means that an increasing number of launches fall into specialty markets and how launch practices are shifting to reflect new dynamics and complexity.

While much of the attention this year has focused on activity in the beltway, healthcare technology continues to introduce innovative and disruptive solutions and services that could offer transformational movement in the way that healthcare is conceived, delivered, accessed, and reimbursed. Mindy and Ryan discuss whether tech can heal the healthcare system with colleagues, Chrisna Govin and Sam Farmer.

In the inaugural episode, Mindy and Ryan discuss how home infusion therapy is part of the broader trend in delivering healthcare in the home to better meet the needs of patients. While many providers and pharmacies are interested in adopting this line of business, there are obstacles to consider. In an interview, guest Connie Sullivan, Vice President of Research and Innovation for the National Home Infusion Association joins us to share what she is observing in the home infusion industry.